Peptides in perimenopause and menopause: a complement, not a substitute

What's actually changing

During perimenopause, ovarian hormone production becomes erratic before it falls. Estrogen swings and then declines, progesterone drops as ovulation becomes irregular and testosterone declines more gradually. The Office on Women's Health lists hot flashes and night sweats, which affect up to three in four women, along with sleep problems, vaginal dryness, irregular periods, urinary changes, mood changes and trouble focusing.

Many of these symptoms trace directly back to estrogen. That's why treatments aimed at other pathways tend to help at the edges, if at all, while the core symptoms continue.

Hormone therapy is the foundation for many women

The Menopause Society calls hormone therapy the most effective treatment for hot flashes. It also relieves night sweats, sleep disruption, vaginal dryness and painful sex, and reduces fracture risk. Starting within 10 years of menopause or before age 60 generally offers the most favorable balance.

It isn't right for everyone. Risks include blood clots and stroke, with clot risk higher for oral than transdermal estrogen, and a possible increase in breast cancer risk with longer use, depending on the regimen. Women with a uterus need a progestogen alongside estrogen to protect the uterine lining. Women with a history of breast or uterine cancer, blood clots, liver disease or cardiovascular disease are generally advised against it. Non-hormonal medicines are available for those who can't or prefer not to use hormones.

Where peptides might complement hormone care

• Weight and metabolism: GLP-1 medicines can help when weight gain is affecting health, and they have large trials behind them. They don't treat hot flashes.
• Sleep and recovery: sermorelin is sometimes considered for sleep and recovery, but evidence in midlife women is limited. Night sweats are a more common cause of broken sleep and respond to hormone therapy.
• Energy: NAD+ is discussed for cellular energy, but a 2023 review found it unclear whether raising NAD+ improves physiological function.
• Libido: bremelanotide (PT-141) is FDA-approved only for premenopausal women; use after menopause is off-label. Vaginal estrogen often helps when pain or dryness is behind low desire.

The honest evidence picture

Most peptide research hasn't focused on women in the menopause transition. Many trials included mostly men or younger adults, and wellness peptides often have little human data at all. That makes it hard to predict how a midlife woman will respond, or what risks might apply alongside hormone therapy.

That doesn't rule peptides out. It means they should be treated as add-ons with uncertain benefit, introduced one at a time with a clear way to measure whether they help.

A sensible order of operations

• Track your symptoms for a few weeks: hot flashes, sleep, mood, cycle changes and energy.
• Rule out other causes of fatigue and weight change, such as thyroid disease, low iron, high blood sugar and sleep apnea.
• Discuss hormone therapy or non-hormonal options for core symptoms.
• Reassess after a few months, once sleep and hot flashes have settled.
• Consider a targeted peptide, such as a GLP-1 medicine for weight, if a specific goal remains.

A whole-person approach

Strength training becomes more important after menopause, because muscle and bone both decline. The CDC recommends muscle-strengthening work on at least 2 days a week. Protein, sleep, alcohol, stress and blood pressure all deserve attention, as cholesterol and blood sugar often rise in this stage.

Skin and hair change too. The American Academy of Dermatology notes that skin loses about 30% of its collagen in the first five years after menopause. Sunscreen and a retinoid have more evidence than injectable peptides for that.

How HealifyMD approaches menopause care

A licensed clinician, with content medically reviewed by board-certified OB-GYN Dr. Vanessa Niles, reviews your symptoms, history and risks. Hormone therapy for women is listed at $349 for the first month (including the evaluation and baseline labs), then $99/month, and includes estradiol options, estriol vaginal cream and progesterone as prescribed. If a peptide makes sense later, your clinician will explain its evidence and regulatory status. Prices are confirmed at your eligibility review, and other labs are priced separately.